Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872903 | 1.00 | CYP19A1 (0.41) | CYP19A1CA12CA1CA2CA9 | |
| SCHEMBL3507005 | 1.00 | CYP19A1 (0.41) | CYP19A1CA12CA1CA2CA9 | |
| SCHEMBL3292504 | 0.86 | ALOX15 (0.37) | CYP19A1ALOX15ALDH1A1TSHRACHE | |
| SCHEMBL3292506 | 0.86 | ALOX15 (0.37) | CYP19A1ALOX15ALDH1A1TSHRACHE | |
| SCHEMBL28250022 | 0.86 | ALOX15 (0.46) | CYP19A1CA12CA1CA2CA9 | |
| SCHEMBL27824849 | 0.85 | TSHR (0.41) | TDP1ALDH1A1TSHRHTTPTPN1 | |
| SCHEMBL11580461 | 0.83 | ALOX15 (0.34) | ALOX15ALDH1A1 | |
| SCHEMBL27008262 | 0.83 | CYP2D6 (0.36) | ALOX15 | |
| SCHEMBL31359288 | 0.83 | PTPN1 (0.37) | CYP19A1CA12CA1CA2CA9 | |
| SCHEMBL873123 | 0.82 | ALOX15 (0.42) | ALOX15TSHRCHRNB2CHRNA4CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20190209441-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-07-11 | — | — | US | claimed |
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | WELLA OPERATIONS US, LLC | 2019-06-27 | — | — | US | claimed |
| US-20190175476-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-06-13 | — | — | US | claimed |
| WO-2018053183-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORPORATION (US) | 2018-03-22 | — | — | WO | claimed |
| WO-2018053065-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-22 | — | — | WO | claimed |
| EP-3295925-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | Noxell Corporation (US) | 2018-03-21 | — | — | EP | claimed |
| WO-2018048924-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| WO-2018048933-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| EP-3290086-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR | Noxell Corporation (US) | 2018-03-07 | — | — | EP | claimed |
| CN-1273127-C | Perfume composition | SHISEIDO CO LTD (JP) | 2006-09-06 | — | — | CN | claimed |
| WO-2006085048-A2 | PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS | FLEXITRAL, INC. (US) | 2006-08-17 | — | — | WO | claimed |
| US-6858575-B2 | Pro-perfume compositions and substrate-treating products and methods using them | PROCTER & GAMBLE COMPANY (US) | 2005-02-22 | — | — | US | claimed |
| US-20040242452-A1 | For effecting mental control through psycho-sedation or psycho-stimulation | SHISEIDO COMPANY, LTD. (JP) | 2004-12-02 | — | — | US | claimed |
| CN-1538840-A | Perfume composition | ������������ʽ���� | 2004-10-20 | — | — | CN | claimed |
| EP-1448757-A1 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2004-08-25 | — | — | EP | claimed |
| EP-1424071-A1 | PERFUME COMPOSITIONS | SHISEIDO COMPANY LIMITED (JP) | 2004-06-02 | — | — | EP | claimed |
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | THE PROCTER & GAMBLE COMPANY | 2003-09-11 | — | — | US | claimed |
| WO-2003046118-A1 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2003-06-05 | — | — | WO | claimed |
| EP-1314777-A1 | Pro-perfume compositions used in cleaning or fabric treatment products | THE PROCTER & GAMBLE COMPANY (US) | 2003-05-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | MAL2, MSH6, OR51E2 | CYP19A1 2001/4885CA12 2307/4885CA1 3296/4885 |
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | FASN, ALOX5, PAM | CYP19A1 542/4885CA12 3116/4885CA1 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.